Furthermore, inhibition of ILK in therapy-resistant CRC cells suppresses levels of EMT and CSC markers and sensitizes the cells to 5-fluorouracil (5-FU) and oxaliplatin [70]. Here, ILK is linked to colorectal carcinoma.